Health Benefits of Functional Oil (Mega 3 Fatty Acids From Fish Oil) on Obese People
NCT ID: NCT01739998
Last Updated: 2012-12-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
52 participants
INTERVENTIONAL
2011-01-31
2011-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
HEALTH_SERVICES_RESEARCH
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
functional oil
Treatment consisted of consuming 5 ml of functional oil \[olive oil (4 ml) with omega 3 fatty acids from fish oil (1 ml: 90% omega 3: 75-80% DHA and 10-15% EPA) Orange flavour\] during the day by 8 weeks.
functional oil
Placebo
Treatment consisted of consuming 5 ml of olive oil during the day by 8 weeks
Placebo
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
functional oil
Placebo
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Body mass index (BMI) ≥ 30 kg/m2
* Signed informed consent.
Exclusion Criteria
* Individuals with Diabetes Mellitus insulin dependent.
* Individuals with disorders associated with eating behaviour.
* Individuals with mental disease or low cognitive function.
* Individuals with consumption of drugs to weight lost.
* Individuals treated with drugs whose direct effect is on lipid profile (statins, fibrates, diuretics, corticosteroids or oral anti-inflammatory).
* Individuals with diseases that could be involucrate in weight lost (not controlled hypothyroidism, serious psychiatric illness, etc.)
* Pregnant women or lactating.
* Individuals with recurrent infections.
* Individuals with regular consumption of anti-inflammatory or glucocorticoids.
* Individuals with consumption of oil fish supplements (except if they gave up its consumption 1 month before).
* Individuals with fish allergy.
* Individuals with consumption of more than two fatty fish servers twice a week.
* Individuals with physical problems complying with the recommendations of physical activity and diet indicated.
30 Years
75 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Instituto de Investigación Hospital Universitario La Paz
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NOBO
Identifier Type: -
Identifier Source: org_study_id